Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis
Conditions: Anti-MDA5 Antibody-positive Dermatomyositis; Respiratory Injury Interventions: Drug: triple therapy; Drug: dual-therapy Sponsor: The First Affiliated Hospital with Nanjing Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials